Insulin Therapy Perspective

• Type 2 Diabetes in a Young Adult With Obesity   A 21-year-old African American male college student has a BMI of 31.2 and type 2 diabetes. He is evaluated by experts who discuss his nutritional education, treatment regimen, and plans for follow-up.
  Medscape, March 21, 2023
• EASD-ADA Report Preferred Over NICE for Hyperglycemia Dr Kevin Fernando explains why he prefers the EASD-ADA consensus report over the NICE guidelines for managing hyperglycemia in type 2 diabetes
  Medscape Diabetes & Endocrinology, February 21, 2023
• How AI and Chatbots Can Make Us Healers Again   ChatGPT and large language models offer physicians the chance to do what they went to medical school for: connect with patients and help them regain their health.
  Medscape, February 21, 2023
• Tidepool Loop Approval Gives More Choice in Managing T1D   The recent FDA approval of the Tidepool Loop app offers patients with type 1 diabetes more choice in managing their disease. Anne L. Peters, MD, explains why.
  Medscape Diabetes & Endocrinology, February 15, 2023
• Decoding Mechanisms of Diabetic Embryopathy Suggests Therapeutic Targets Experts discuss the characteristics of embryos from women with diabetes.
  MDedge, December 21, 2022
• Meditation Instead of Medication in Type 2 Diabetes? Recent studies suggest that mind-body practices can improve glycemic control in patients with type 2 diabetes. Dr Akshay Jain provides insight into this research.
  Medscape Diabetes & Endocrinology, November 30, 2022
• 'First Step' Toward Delaying Progression of Type 1 Diabetes   Dr Anne Peters discusses the approval of teplizumab and its potential impact in delaying the onset of stage 3 diabetes for patients age 8 years or older who currently have stage 2 type 1 diabetes.
  Medscape Diabetes & Endocrinology, November 22, 2022
• Flash CGM Sustainably Reduces Acute Hospitalizations in T2D   Jean-Pierre Riveline, PhD, discusses results from a study demonstrating how continuous glucose monitoring may be used to fight clinical inertia.
  Medscape Diabetes & Endocrinology, October 21, 2022
• Nurses Questions Answered: When Politics Divides the Team An experienced nurse discusses workplace issues, including political differences, privacy violations, and whether staff should hide their medical devices.
  Medscape Nurses, October 21, 2022
• Advances in Insulin Therapy for Type 2 Diabetes From EASD 2022   From EASD 2022, Dr Anne Peters reports on the latest updates on insulin therapy for T2D, including the data from the ONWARDS 2 trial and a subanalysis of the SoliMix trial.
  Medscape, October 12, 2022
• Reducing Waste, Going Green With Diabetes Technology   What are the initiatives to decrease waste from diabetes technology? Lutz Heinemann, PhD, discusses steps to move toward green diabetes.
  Medscape Diabetes & Endocrinology, September 29, 2022
• The Bionic Pancreas Triumphs in Pivotal Trial   We are closer than ever to a truly hands-free closed-loop insulin delivery system for type 1 diabetes.
  Medscape, September 28, 2022
• Integrated Care and New Technologies in Type 1 Diabetes   Chantal Mathieu, MD, PhD, discusses access to care, integrated care, and new technologies in type 1 diabetes.
  Medscape Diabetes & Endocrinology, August 25, 2022
• Automated Insulin Delivery: The Next Generation of Research   Greg Forlenza, MD, discusses the next generation of automated insulin delivery research.
  Medscape Diabetes & Endocrinology, August 23, 2022
• Closing the Gap on Diabetes Care in Minority Populations   Andrea Gerard Gonzalez, MD, discusses the programs that the Barbara Davis Center Latino Center has implemented to provide better diabetes care to minority populations.
  Medscape Diabetes & Endocrinology, August 09, 2022
• S1 Episode 6: Future Type 2 Diabetes Drugs: Exciting and a Little Scary   Who's likely to benefit from more nuanced diabetes treatments, and how might these agents advance diabetes care? Silvio Inzucchi, MD, and Joshua Neumiller, PharmD, dig deep into recent drug developments.
  Medscape, July 12, 2022
• More Holistic Approach Needed for Hyperglycemia Management   Dr John Buse discusses the updated ADA-EASD consensus on managing hyperglycemia, including glycemic and weight management, cardiovascular risk reduction, and cardiorenal therapies or organ protection.
  Medscape Diabetes & Endocrinology, June 23, 2022
• iLet System Simplifies Insulin Delivery for T1D   Dr Anne Peters offers perspective on how the iLet automated insulin system works and can improve management for patients with type 1 diabetes.
  Medscape Diabetes & Endocrinology, June 07, 2022
• ADA 2022 Read clinically focused news coverage of key developments from ADA 2022
  Medscape Diabetes & Endocrinology, June 01, 2022
• 'Turning Red' Provides Positive Depiction of Diabetes Pixar's newest animated film features two background characters with visible diabetes technology, a leap forward in portrayals of diabetes in mainstream media.
  Medscape Diabetes & Endocrinology, June 01, 2022